Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Effects of Zoledronic Acid (Zometa) and Physical Activity on Bone Density in Women Receiving Chemotherapy for Breast Cancer

NCT00202059 is registered in ClinicalTrials.gov with HealthPartners Institute as lead sponsor.

NCT NCT00202059
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00202059 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Effects of Zoledronic Acid (Zometa) and Physical Activity on Bone Density in Women Receiving Chemotherapy for Breast Cancer
Lead sponsor
HealthPartners Institute
Phase
Phase 3
Overall status
Completed
Start date
June 30, 2003
Completion date
September 30, 2007
Enrollment
72
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

breast cancer